ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED
ActiveKey figures
Like most small UK companies, ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Sector comparison
SIC 21100Where the company stands among the 1,055 active companies whose first SIC code is 21100 (Manufacture of basic pharmaceutical products).
- GE HEALTHCARE LIMITED£5.6bn
- THERMO FISHER SCIENTIFIC LIFE HOLDINGS LIMITED£1.4bn
- LRC PRODUCTS LIMITED£1bn
- SMITHKLINE BEECHAM LIMITED£940m
- DECHRA LIMITED£780.1m
- IPSEN BIOPHARM LIMITED£588.2m
- ORTHO-CLINICAL DIAGNOSTICS£295.7m
- BESPAK EUROPE LIMITED£256m
- SEQIRUS VACCINES LIMITED£254.2m
- IOVANCE BIOTHERAPEUTICS UK LTD£199.7m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant. The line on each bar marks the median.
Summary: ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED
What kind of company is it?
ENNOGEN HEALTHCARE DEVELOPMENTS LIMITED is a private limited company registered with Companies House under company number 16539429. It was incorporated on 24 Jun 2025. Its status is active. The registered office is in Dartford (DA1). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), wholesale of pharmaceutical goods (46460).
How is the company doing financially?
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files dormant company accounts. Net assets were £1. The company had an average of 0 employees.
How does it compare with similar companies?
Compared with 1,055 active companies whose first SIC code is 21100: It is younger than 85% of them (median age 9.0 years).
Who runs and controls the company?
One person with significant control is registered.
When are its next filings due?
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 3 Jul 2027.
Filed accounts2025
| 2025 | |
|---|---|
| Total assets | 1 |
| Total liabilities | — |
| Net assets / total equity | 1 |
| Average number of employees | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Manufacture of basic pharmaceutical products
As described in the company's latest filed accounts.
History
3 events- Financial year 2025 endedAccounts: net assets £1, 0 employees
- Ennogen Investments Ltd registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.